Schedule 13G ownership disclosure
Bright Minds Biosciences Inc
Common Shares, without par value · CUSIP: 10919W405
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- COMMODORE CAPITAL LP
Shares: 500,000.00 · Class: 7.2%
- Commodore Capital Master LP
Shares: 500,000.00 · Class: 7.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-006845
- Form type
- SCHEDULE 13G/A
- Filer
- BRIGHT MINDS BIOSCIENCES INC.
- CIK
- CIK 1827401
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership